Cowen and Company’s FTAC Hera Acquisition Corp. Warrant HERAW Stock Holding History

Cowen and Company’s Portfolio HERAW Stock Details HERAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,514,041	Closed	-$41.6K	–	779
2022 Q4	$41.6K	Buy	1,514,041 +370,626	+32%	+$15K	﹤0.01%	275
2022 Q3	$98K	Buy	1,143,415 +195,145	+21%	+$26.4K	0.01%	220
2022 Q2	$227K	Buy	948,270 +912,354	+2,540%	+$271K	0.02%	199
2022 Q1	$16K	Sell	35,916 -93,556	-72%	-$53K	﹤0.01%	461
2021 Q4	$123K	Buy	129,472 +7,137	+6%	+$7.07K	0.01%	349
2021 Q3	$126K	Buy	+122,335	New	+$144K	0.01%	299

Cowen and Company's HERAW Position: Q1 2023 in Review

Cowen and Company sold out of FTAC Hera Acquisition Corp. Warrant (HERAW) in Q1 2023, closing a stake of 1,514,041 shares — an estimated $41.6K sold.

Cowen and Company first reported a position in HERAW in Q3 2021 and held it in 6 quarters. The position peaked at $227K in Q2 2022. 0 funds tracked by Wall St. Rank hold HERAW as of Q1 2023.

Cowen and Company reported no remaining FTAC Hera Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Cowen and Company sold 1,514,041 FTAC Hera Acquisition Corp. Warrant shares in Q1 2023, an estimated $41.6K.
Cowen and Company first reported a position in FTAC Hera Acquisition Corp. Warrant in Q3 2021 and held it in 6 quarters.
Cowen and Company's FTAC Hera Acquisition Corp. Warrant position peaked at $227K in Q2 2022.
0 funds tracked by Wall St. Rank held FTAC Hera Acquisition Corp. Warrant as of Q1 2023.

Based on Cowen and Company's 13F filing for Q1 2023, filed 9 May 2023.